Do you have Type 2 Diabetes? Are you 18 years or older? Not currently taking Insulin? Are you currently being treated with stable doses of daily or weekly GLP-1 receptor agonist? This 52 week research study is seeking qualified participants to help compare the efficacy and safety of once weekly IcoSema and once weekly semaglutide. Qualified participants will receive study drug free of charge and may be compensated for time and travel. The treatment can be with or without any of the following anti-diabetic drugs with stable doses: Metformin, Sulfonylureasa , Meglitinides (glinides), DPP-4 inhibitors, Sodium-glucose co-transporter 2 inhibitors, Alpha-glucosidase-inhibitors, and Thiazolidinediones. For more information, and to see if you might be eligible to join, please contact 205-996-4015 or email at firstname.lastname@example.org.